{
  "trial_id": "NCT03844789",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, weight, duration of type 1 diabetes, total daily insulin dose, use of carbohydrate ratio for meal boluses, use of contraception (for females of child-bearing potential), familiarity with emergency procedures for severe hypoglycemia, current use of insulin type (lispro or aspart), willingness to switch insulin type, participation in training sessions, concurrent use of non-insulin glucose-lowering agents, presence of bleeding disorders, participation in other trials, employment status related to Tandem Diabetes Care, Inc.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Diabetes Duration",
          "duration of type 1 diabetes"
        ],
        [
          "Total Daily Insulin",
          "total daily insulin dose"
        ],
        [
          "Severe Hypoglycemia (SH) in Last 12 Months",
          "familiarity with emergency procedures for severe hypoglycemia"
        ],
        [
          "Insulin Modality",
          "current use of insulin type (lispro or aspart)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Body Mass Index (BMI) Z-score",
        "Parents Education",
        "Annual Household Income",
        "Health Insurance",
        "HbA1c Local Lab at Screening",
        "HbA1c Central Lab at Randomization",
        "C-peptide (nmol/L)",
        "Diabetic Ketoacidosis (DKA) in Last 12 Months"
      ],
      "remaining_candidate_features": [
        "weight",
        "use of carbohydrate ratio for meal boluses",
        "use of contraception (for females of child-bearing potential)",
        "willingness to switch insulin type",
        "participation in training sessions",
        "concurrent use of non-insulin glucose-lowering agents",
        "presence of bleeding disorders",
        "participation in other trials",
        "employment status related to Tandem Diabetes Care",
        "Inc."
      ]
    },
    "processed-gen-response": "Age, sex, weight, duration of type 1 diabetes, total daily insulin dose, use of carbohydrate ratio for meal boluses, use of contraception (for females of child-bearing potential), familiarity with emergency procedures for severe hypoglycemia, current use of insulin type (lispro or aspart), willingness to switch insulin type, participation in training sessions, concurrent use of non-insulin glucose-lowering agents, presence of bleeding disorders, participation in other trials, employment status related to Tandem Diabetes Care, Inc."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Weight, Duration of Diabetes, Total Daily Insulin Dose, Baseline HbA1c, Use of Carbohydrate Ratio for Meal Boluses,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Diabetes Duration",
          "Duration of Diabetes"
        ],
        [
          "Total Daily Insulin",
          "Total Daily Insulin Dose"
        ]
      ],
      "remaining_reference_features": [
        "Insulin Modality",
        "Body Mass Index (BMI) Z-score",
        "Parents Education",
        "Annual Household Income",
        "Health Insurance",
        "HbA1c Local Lab at Screening",
        "HbA1c Central Lab at Randomization",
        "C-peptide (nmol/L)",
        "Diabetic Ketoacidosis (DKA) in Last 12 Months",
        "Severe Hypoglycemia (SH) in Last 12 Months"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Weight",
        "Baseline HbA1c",
        "Use of Carbohydrate Ratio for Meal Boluses"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Weight, Duration of Diabetes, Total Daily Insulin Dose, Baseline HbA1c, Use of Carbohydrate Ratio for Meal Boluses"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Diagnosis Duration, Insulin Dose, BMI, HbA1c, Total Daily Insulin Dose, Parent/Legal Guardian Education Level, Parent/Legal Guardian Occupation.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Diabetes Duration",
          "Diabetes Diagnosis Duration"
        ],
        [
          "Insulin Modality",
          "Insulin Dose"
        ],
        [
          "Body Mass Index (BMI) Z-score",
          "BMI"
        ],
        [
          "Parents Education",
          "Parent/Legal Guardian Education Level"
        ],
        [
          "Total Daily Insulin",
          "Total Daily Insulin Dose"
        ]
      ],
      "remaining_reference_features": [
        "Annual Household Income",
        "Health Insurance",
        "HbA1c Local Lab at Screening",
        "HbA1c Central Lab at Randomization",
        "C-peptide (nmol/L)",
        "Diabetic Ketoacidosis (DKA) in Last 12 Months",
        "Severe Hypoglycemia (SH) in Last 12 Months"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "HbA1c",
        "Parent/Legal Guardian Occupation"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Diabetes Diagnosis Duration, Insulin Dose, BMI, HbA1c, Total Daily Insulin Dose, Parent/Legal Guardian Education Level, Parent/Legal Guardian Occupation."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, weight, height, body mass index (BMI), duration of type 1 diabetes, insulin dose (total daily dose, basal, and bolus), hemoglobin A1c (HbA1c), carbohydrate ratio, type of insulin used, presence of diabetic complications, history of severe hypoglycemia, presence of other medical conditions, use of concomitant medications.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Diabetes Duration",
          "duration of type 1 diabetes"
        ],
        [
          "Insulin Modality",
          "type of insulin used"
        ],
        [
          "Total Daily Insulin",
          "insulin dose (total daily dose, basal, and bolus)"
        ],
        [
          "Severe Hypoglycemia (SH) in Last 12 Months",
          "history of severe hypoglycemia"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Body Mass Index (BMI) Z-score",
        "Parents Education",
        "Annual Household Income",
        "Health Insurance",
        "HbA1c Local Lab at Screening",
        "HbA1c Central Lab at Randomization",
        "C-peptide (nmol/L)",
        "Diabetic Ketoacidosis (DKA) in Last 12 Months"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "body mass index (BMI)",
        "hemoglobin A1c (HbA1c)",
        "carbohydrate ratio",
        "presence of diabetic complications",
        "presence of other medical conditions",
        "use of concomitant medications."
      ]
    },
    "processed-gen-response": "Age, sex, weight, height, body mass index (BMI), duration of type 1 diabetes, insulin dose (total daily dose, basal, and bolus), hemoglobin A1c (HbA1c), carbohydrate ratio, type of insulin used, presence of diabetic complications, history of severe hypoglycemia, presence of other medical conditions, use of concomitant medications."
  }
}